APA (7th ed.) Citation

Simeone, E., Scognamiglio, G., Capone, M., Giannarelli, D., Grimaldi, A. M., Mallardo, D., . . . Ascierto, P. A. (2021). A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation. Journal of translational medicine, 19(1), 17-10. https://doi.org/10.1186/s12967-020-02680-7

Chicago Style (17th ed.) Citation

Simeone, Ester, et al. "A Monocentric Phase I Study of Vemurafenib Plus Cobimetinib Plus PEG-interferon (VEMUPLINT) in Advanced Melanoma Patients Harboring the V600BRAF Mutation." Journal of Translational Medicine 19, no. 1 (2021): 17-10. https://doi.org/10.1186/s12967-020-02680-7.

MLA (9th ed.) Citation

Simeone, Ester, et al. "A Monocentric Phase I Study of Vemurafenib Plus Cobimetinib Plus PEG-interferon (VEMUPLINT) in Advanced Melanoma Patients Harboring the V600BRAF Mutation." Journal of Translational Medicine, vol. 19, no. 1, 2021, pp. 17-10, https://doi.org/10.1186/s12967-020-02680-7.